Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1996 Nov;33(11):935–939. doi: 10.1136/jmg.33.11.935

Splicing mutations in DMD/BMD detected by RT-PCR/PTT: detection of a 19AA insertion in the cysteine rich domain of dystrophin compatible with BMD.

P A Roest 1, M Bout 1, A C van der Tuijn 1, I B Ginjaar 1, E Bakker 1, F B Hogervorst 1, G J van Ommen 1, J T den Dunnen 1
PMCID: PMC1050788  PMID: 8950674

Abstract

We have used an RNA based mutation detection method to screen the total coding region of the dystrophin gene of a Duchenne and a Becker muscular dystrophy patient in whom DNA based mutation detection methods have so far failed to detect mutations. By RT-PCR and the protein truncation test (PTT) we could identify point mutations in both cases. DMD patient DL184.3 has a T-->A mutation in intron 59 at position -9, creating a novel splice acceptor site for exon 60. As a result seven intronic bases are spliced into the mRNA, causing a frameshift and premature translation termination 20 codons downstream. Since this patient had died and only fibroblasts were available, we applied MyoD induced myodifferentiation of stored fibroblasts to enhance muscle specific gene expression. With the results of this mutation analysis, prenatal diagnosis could subsequently be performed in this family. BMD patient BL207.1 carries a G-->C mutation at position +5 of intron 64, disrupting the splice donor consensus sequence and activating a cryptic splice donor site 57bp downstream. The inclusion of these 57 intronic bases in the mRNA leaves the reading frame open and results in the insertion of 19 amino acids into the cysteine rich domain of dystrophin. Interestingly, this insertion in a part of the dystrophin considered to interact with the dystrophin binding complex of the sarcolemma is apparently compatible with mild BMD-like clinical features. Both mutations reported are missed by analysis of multiplex PCR products designed for deletion screening of the coding region. Extrapolation from existing point mutation detection efficiencies by DNA and RNA based methods emphasises that RNA based methods are more sensitive and that most of the remaining undetected mutations may affect splice or branch sites or create cryptic splice sites.

Full text

PDF
935

Images in this article

936Image
on p.936

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beggs A. H., Koenig M., Boyce F. M., Kunkel L. M. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990 Nov;86(1):45–48. doi: 10.1007/BF00205170. [DOI] [PubMed] [Google Scholar]
  2. Byers T. J., Lidov H. G., Kunkel L. M. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet. 1993 May;4(1):77–81. doi: 10.1038/ng0593-77. [DOI] [PubMed] [Google Scholar]
  3. Chamberlain J. S., Gibbs R. A., Ranier J. E., Nguyen P. N., Caskey C. T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988 Dec 9;16(23):11141–11156. doi: 10.1093/nar/16.23.11141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Comi G. P., Ciafaloni E., de Silva H. A., Prelle A., Bardoni A., Rigoletto C., Robotti M., Bresolin N., Moggio M., Fortunato F. A G+1-->A transversion at the 5' splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp116 and severe clinical involvement in a DMD patient. Hum Mol Genet. 1995 Nov;4(11):2171–2174. doi: 10.1093/hmg/4.11.2171. [DOI] [PubMed] [Google Scholar]
  5. Den Dunnen J. T., Grootscholten P. M., Bakker E., Blonden L. A., Ginjaar H. B., Wapenaar M. C., van Paassen H. M., van Broeckhoven C., Pearson P. L., van Ommen G. J. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 1989 Dec;45(6):835–847. [PMC free article] [PubMed] [Google Scholar]
  6. Gardner R. J., Bobrow M., Roberts R. G. The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test. Am J Hum Genet. 1995 Aug;57(2):311–320. [PMC free article] [PubMed] [Google Scholar]
  7. Kilimann M. W., Pizzuti A., Grompe M., Caskey C. T. Point mutations and polymorphisms in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR. Hum Genet. 1992 May;89(3):253–258. doi: 10.1007/BF00220535. [DOI] [PubMed] [Google Scholar]
  8. Kneppers A. L., Deutz-Terlouw P. P., den Dunnen J. T., van Ommen G. J., Bakker E. Point mutation screening for 16 exons of the dystrophin gene by multiplex single-strand conformation polymorphism analysis. Hum Mutat. 1995;5(3):235–242. doi: 10.1002/humu.1380050308. [DOI] [PubMed] [Google Scholar]
  9. Koenig M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., Kunkel L. M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987 Jul 31;50(3):509–517. doi: 10.1016/0092-8674(87)90504-6. [DOI] [PubMed] [Google Scholar]
  10. Koenig M., Monaco A. P., Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988 Apr 22;53(2):219–228. doi: 10.1016/0092-8674(88)90383-2. [DOI] [PubMed] [Google Scholar]
  11. Lederfein D., Levy Z., Augier N., Mornet D., Morris G., Fuchs O., Yaffe D., Nudel U. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5346–5350. doi: 10.1073/pnas.89.12.5346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lenk U., Hanke R., Thiele H., Speer A. Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients. Hum Mol Genet. 1993 Nov;2(11):1877–1881. doi: 10.1093/hmg/2.11.1877. [DOI] [PubMed] [Google Scholar]
  13. Lidov H. G., Selig S., Kunkel L. M. Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet. 1995 Mar;4(3):329–335. doi: 10.1093/hmg/4.3.329. [DOI] [PubMed] [Google Scholar]
  14. Monaco A. P., Bertelson C. J., Liechti-Gallati S., Moser H., Kunkel L. M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988 Jan;2(1):90–95. doi: 10.1016/0888-7543(88)90113-9. [DOI] [PubMed] [Google Scholar]
  15. Monaco A. P., Bertelson C. J., Middlesworth W., Colletti C. A., Aldridge J., Fischbeck K. H., Bartlett R., Pericak-Vance M. A., Roses A. D., Kunkel L. M. Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. 1985 Aug 29-Sep 4Nature. 316(6031):842–845. doi: 10.1038/316842a0. [DOI] [PubMed] [Google Scholar]
  16. Nigro V., Politano L., Nigro G., Romano S. C., Molinari A. M., Puca G. A. Detection of a nonsense mutation in the dystrophin gene by multiple SSCP. Hum Mol Genet. 1992 Oct;1(7):517–520. doi: 10.1093/hmg/1.7.517. [DOI] [PubMed] [Google Scholar]
  18. Prior T. W., Bartolo C., Pearl D. K., Papp A. C., Snyder P. J., Sedra M. S., Burghes A. H., Mendell J. R. Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet. 1995 Jul;57(1):22–33. [PMC free article] [PubMed] [Google Scholar]
  19. Prior T. W., Papp A. C., Snyder P. J., Burghes A. H., Sedra M. S., Western L. M., Bartello C., Mendell J. R. Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation. Hum Mol Genet. 1993 Mar;2(3):311–313. doi: 10.1093/hmg/2.3.311. [DOI] [PubMed] [Google Scholar]
  20. Prior T. W., Papp A. C., Snyder P. J., Sedra M. S., Western L. M., Bartolo C., Moxley R. T., Mendell J. R. Heteroduplex analysis of the dystrophin gene: application to point mutation and carrier detection. Am J Med Genet. 1994 Mar 1;50(1):68–73. doi: 10.1002/ajmg.1320500115. [DOI] [PubMed] [Google Scholar]
  21. Roberts R. G., Bobrow M., Bentley D. R. Point mutations in the dystrophin gene. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2331–2335. doi: 10.1073/pnas.89.6.2331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Roberts R. G., Gardner R. J., Bobrow M. Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum Mutat. 1994;4(1):1–11. doi: 10.1002/humu.1380040102. [DOI] [PubMed] [Google Scholar]
  23. Roberts R. G., Passos-Bueno M. R., Bobrow M., Vainzof M., Zatz M. Point mutation in a Becker muscular dystrophy patient. Hum Mol Genet. 1993 Jan;2(1):75–77. doi: 10.1093/hmg/2.1.75. [DOI] [PubMed] [Google Scholar]
  24. Roest P. A., Roberts R. G., Sugino S., van Ommen G. J., den Dunnen J. T. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet. 1993 Oct;2(10):1719–1721. doi: 10.1093/hmg/2.10.1719. [DOI] [PubMed] [Google Scholar]
  25. Saad F. A., Vitiello L., Merlini L., Mostacciuolo M. L., Oliviero S., Danieli G. A. A 3' consensus splice mutation in the human dystrophin gene detected by a screening for intra-exonic deletions. Hum Mol Genet. 1992 Aug;1(5):345–346. doi: 10.1093/hmg/1.5.345. [DOI] [PubMed] [Google Scholar]
  26. Sancho S., Mongini T., Tanji K., Tapscott S. J., Walker W. F., Weintraub H., Miller A. D., Miranda A. F. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy. N Engl J Med. 1993 Sep 23;329(13):915–920. doi: 10.1056/NEJM199309233291303. [DOI] [PubMed] [Google Scholar]
  27. Shapiro M. B., Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987 Sep 11;15(17):7155–7174. doi: 10.1093/nar/15.17.7155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Suzuki A., Yoshida M., Yamamoto H., Ozawa E. Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett. 1992 Aug 17;308(2):154–160. doi: 10.1016/0014-5793(92)81265-n. [DOI] [PubMed] [Google Scholar]
  29. Wilton S. D., Chandler D. C., Kakulas B. A., Laing N. G. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family. Hum Mutat. 1994;3(2):133–140. doi: 10.1002/humu.1380030208. [DOI] [PubMed] [Google Scholar]
  30. Wilton S. D., Johnsen R. D., Pedretti J. R., Laing N. G. Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation. Am J Med Genet. 1993 Jun 15;46(5):563–569. doi: 10.1002/ajmg.1320460521. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES